As of 2025-04-29, the Intrinsic Value of Ikena Oncology Inc (IKNA) is -6.11 USD. This IKNA valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.19 USD, the upside of Ikena Oncology Inc is -613.84%.
Based on its market price of 1.19 USD and our intrinsic valuation, Ikena Oncology Inc (IKNA) is overvalued by 613.84%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.11 - -6.11 | -6.11 | -613.84% |
| P/E | (38.74) - (51.76) | (45.68) | -3938.4% |
| DDM - Stable | (9.85) - (25.39) | (17.62) | -1580.9% |
| DDM - Multi | (8.45) - (17.17) | (11.35) | -1053.9% |
| Market Cap (mil) | 47.91 |
| Beta | 0.70 |
| Outstanding shares (mil) | 40.26 |
| Enterprise Value (mil) | 8.51 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.51% |
| Cost of Debt | 5.00% |
| WACC | 7.09% |